Is more clarity needed in the HSE's drugs group decision making? episode artwork

EPISODE · Aug 21, 2026 · 8 MIN

Is more clarity needed in the HSE's drugs group decision making?

from The Hard Shoulder

The HSE drugs group’s recommendation to refuse reimbursement for the drug Skyclarys is a stark reminder of the devastating human cost that can lie behind bureaucratic decisions. So wrote Consultant in Paediatric Intensive Care, Dr Suzanne Crowe, in The Journal yesterday.She joins Ciara to discuss.

Episode metadata supplied by the publisher feed · Published Aug 21, 2026

Embed this episode

NOW PLAYING

Is more clarity needed in the HSE's drugs group decision making?

0:00 8:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Hard Shoulder?

This episode is 8 minutes long.

When was this The Hard Shoulder episode published?

This episode was published on August 21, 2026.

Can I download this The Hard Shoulder episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!